C12N 9/93
Ligases
Official title: {Ligases (6)}
C12N9/93 (Ligases) appears on 1,817 US grants and 2,596 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,817
- Published applications
- 2,596
- Assignees
- 1,041
- Inventors
- 5,092
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 5 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 14 | 0 |
| 1997 | 22 | 0 |
| 1998 | 64 | 0 |
| 1999 | 74 | 0 |
| 2000 | 60 | 0 |
| 2001 | 67 | 6 |
| 2002 | 38 | 61 |
| 2003 | 29 | 95 |
| 2004 | 24 | 76 |
| 2005 | 37 | 75 |
| 2006 | 31 | 77 |
| 2007 | 41 | 64 |
| 2008 | 28 | 68 |
| 2009 | 34 | 79 |
| 2010 | 52 | 90 |
| 2011 | 46 | 67 |
| 2012 | 64 | 88 |
| 2013 | 53 | 119 |
| 2014 | 53 | 120 |
| 2015 | 101 | 145 |
| 2016 | 83 | 105 |
| 2017 | 108 | 133 |
| 2018 | 81 | 116 |
| 2019 | 69 | 100 |
| 2020 | 94 | 122 |
| 2021 | 78 | 125 |
| 2022 | 84 | 134 |
| 2023 | 66 | 123 |
| 2024 | 50 | 141 |
| 2025 | 79 | 139 |
| 2026 | 57 | 128 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Paenibacillus strain, antifungal compounds, and methods for their use6 Oct 2026US 12,753,207 B2Bayer CropScience AG
- Method for the biosynthesis of diosmin and/or hesperidin in a microorganism29 Sep 2026US 12,747,464 B2Les Laboratoires Servier
- Recombinant host cells with improved production of tetraketide derivatives22 Sep 2026US 12,742,189 B2Iptector Assets Aps
- Modified UBE3A gene for a gene therapy approach for Angelman syndrome15 Sep 2026US 12,734,250 B2University of South Florida
- Mutant enzyme, use thereof and process for preparing tripeptide by using enzymatic method15 Sep 2026US 12,735,694 B2Shenzhen Readline Biotech Co., Ltd.
- Method for genetically encoding 2-aminoisobutyric acid and its analogs and applications thereof8 Oct 2026US 2026/0308223 A1Edipro Pharmaceutical Technology Inc.
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- In-vitro cell-free protein synthesis system for inserting non-natural amino acid, and method and use8 Oct 2026US 2026/0308653 A1Kangma-Healthcode (Shanghai) Biotech Co., Ltd.
- Therapeutic circular dna forms1 Oct 2026US 2026/0294957 A1Flagship Pioneering Innovations Vii, LLC
- Recombinant expression vector for production of virus-like particle-based multivalent norovirus vaccine and manufacturing method therefor24 Sep 2026US 2026/0284173 A1Inthera Inc.
Most cited
By later US patents
- Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease941US 5,494,810 ACornell Research Foundation, Inc. · 1996
- Stacked herbicide tolerance event 8264.44.06.1, related transgenic soybean lines, and detection thereof661US 9,540,655 B2Dow AgroSciences LLC · 2017
- Thermostable ligase mediated DNA amplification system for the detection of genetic diseases352US 5,830,711 ACalifornia Institute of Technology · 1998
- In vivo incorporation of unnatural amino acids304US 7,045,337 B2The Regents of the University of California · 2006
- Method for dominant selection in eucaryotic cells277US 5,122,464 ACelltech Limited, a British Company · 1992